We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Califf: Diabetes, Weight Loss, Alzheimer’s Drugs Could Be “Major Game Changers”
Califf: Diabetes, Weight Loss, Alzheimer’s Drugs Could Be “Major Game Changers”
FDA Commissioner Robert Califf said Alzheimer’s disease drugs and glucagon-like peptide-1 (GLP-1) agonists for diabetes and obesity could be “major game changers in the ongoing battle with chronic diseases that cause the vast majority of death and disability in our country.”